These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34047071)

  • 1. Targeting the S100A2-p53 Interaction with a Series of 3,5-Bis(trifluoromethyl)benzene Sulfonamides: Synthesis and Cytotoxicity.
    Sun J; Ambrus JI; Russell CC; Baker JR; Cossar PJ; Pirinen MJ; Sakoff JA; Scarlett CJ; McCluskey A
    ChemMedChem; 2021 Sep; 16(18):2851-2863. PubMed ID: 34047071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic 1,2,3-Triazoles as Potential Leads Targeting the S100A2-p53 Complex: Synthesis and Cytotoxicity.
    Sun J; Baker JR; Russell CC; Cossar PJ; Ngoc Thuy Pham H; Sakoff JA; Scarlett CJ; McCluskey A
    ChemMedChem; 2021 Sep; 16(18):2864-2881. PubMed ID: 34047450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety.
    Sun J; Ambrus JI; Baker JR; Russell CC; Cossar PJ; Sakoff JA; Scarlett CJ; McCluskey A
    Bioorg Med Chem Lett; 2022 Apr; 61():128591. PubMed ID: 35114371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer.
    Sun J; Baker JR; Russell CC; Pham HNT; Goldsmith CD; Cossar PJ; Sakoff JA; Scarlett CJ; McCluskey A
    RSC Med Chem; 2023 Nov; 14(11):2246-2267. PubMed ID: 37974967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity.
    Mueller A; Schäfer BW; Ferrari S; Weibel M; Makek M; Höchli M; Heizmann CW
    J Biol Chem; 2005 Aug; 280(32):29186-93. PubMed ID: 15941720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
    Buckley NE; D'Costa Z; Kaminska M; Mullan PB
    Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of a Synthesized Library of N-Benzyl Sulfonamides Derived from an Indole Core to Target Pancreatic Cancer.
    Hopkins MD; Costello IJ; Brandeburg ZC; Slay EL; Zanders LA; Dunn CE; Derewonko CA; Davitt CL; Reeder MA; Prichard K; Chiew B; McCluskey A; Sheaff RJ; Lamar AA
    ChemMedChem; 2023 Oct; 18(19):e202300265. PubMed ID: 37421174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The p53-S100A2 Positive Feedback Loop Negatively Regulates Epithelialization in Cutaneous Wound Healing.
    Pan SC; Li CY; Kuo CY; Kuo YZ; Fang WY; Huang YH; Hsieh TC; Kao HY; Kuo Y; Kang YR; Tsai WC; Tsai ST; Wu LW
    Sci Rep; 2018 Apr; 8(1):5458. PubMed ID: 29615682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy.
    Patrício RPS; Videira PA; Pereira F
    Bioorg Med Chem; 2022 Jan; 53():116530. PubMed ID: 34861473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the human S100A2 promoter by wild-type p53.
    Tan M; Heizmann CW; Guan K; Schafer BW; Sun Y
    FEBS Lett; 1999 Feb; 445(2-3):265-8. PubMed ID: 10094469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of S100A2 expression by TGF-β-induced MEK/ERK signalling and its role in cell migration/invasion.
    Naz S; Ranganathan P; Bodapati P; Shastry AH; Mishra LN; Kondaiah P
    Biochem J; 2012 Oct; 447(1):81-91. PubMed ID: 22747445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Quinoline Based Sulfonamide Derivatives: Cytotoxic and Apoptotic Activity Evaluation Against Pancreatic Cancer Cells.
    Yurttaş L; Çiftçi GA
    Anticancer Agents Med Chem; 2018; 18(8):1122-1130. PubMed ID: 29521252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors.
    Hu C; Li X; Wang W; Zhang L; Tao L; Dong X; Sheng R; Yang B; Hu Y
    Bioorg Med Chem; 2011 Sep; 19(18):5454-61. PubMed ID: 21855354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential responses of S100A2 to oxidative stress and increased intracellular calcium in normal, immortalized, and malignant human keratinocytes.
    Zhang T; Woods TL; Elder JT
    J Invest Dermatol; 2002 Nov; 119(5):1196-201. PubMed ID: 12445212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-pot synthesis of spiro(indoline-3,4'-pyrazolo[3,4-b]pyridine)-5'-carbonitriles as p53-MDM2 interaction inhibitors.
    Ibrahim HS; Eldehna WM; Fallacara AL; Ahmed ER; Ghabbour HA; Elaasser MM; Botta M; Abou-Seri SM; Abdel-Aziz HA
    Future Med Chem; 2018 Dec; 10(24):2771-2789. PubMed ID: 30526032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic expression of S100A2 in hairless mouse skin enhances Cxcl13 mRNA in response to solar-simulated radiation.
    Li Y; Gudjonsson JE; Woods TL; Zhang T; Johnston A; Stoll SW; Elder JT
    Arch Dermatol Res; 2009 Mar; 301(3):205-17. PubMed ID: 18773213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Profile of S100A2 and its Clinicopathological Significance in Renal Cell Carcinoma.
    Sugiyama T; Ozono S; Miyake H
    Anticancer Res; 2020 Nov; 40(11):6337-6343. PubMed ID: 33109571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Diarylpentanoid with Potential Activation of the p53 Pathway: Combination of in silico Screening Studies, Synthesis, and Biological Activity Evaluation.
    Moreira J; Almeida J; Loureiro JB; Ramos H; Palmeira A; Pinto MM; Saraiva L; Cidade H
    ChemMedChem; 2021 Oct; 16(19):2969-2981. PubMed ID: 34170069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel 3,4,5-trisubstituted aminothiophenes as inhibitors of p53-MDM2 interaction. Part 2.
    Wang W; Lv D; Qiu N; Zhang L; Hu C; Hu Y
    Bioorg Med Chem; 2013 Jun; 21(11):2886-94. PubMed ID: 23611770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3.
    Naz S; Bashir M; Ranganathan P; Bodapati P; Santosh V; Kondaiah P
    Carcinogenesis; 2014 Jan; 35(1):14-23. PubMed ID: 23996929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.